These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7985031)

  • 1. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
    McCord JM
    Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
    [No Abstract]   [Full Text] [Related]  

  • 2. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis.
    Kruman II; Pedersen WA; Springer JE; Mattson MP
    Exp Neurol; 1999 Nov; 160(1):28-39. PubMed ID: 10630188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
    Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
    Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
    Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
    Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
    Nakano R
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial alterations in transgenic mice with an H46R mutant Cu/Zn superoxide dismutase gene.
    Sasaki S; Aoki M; Nagai M; Kobayashi M; Itoyama Y
    J Neuropathol Exp Neurol; 2009 Apr; 68(4):365-73. PubMed ID: 19287315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
    Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
    Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.
    Gurney ME; Pu H; Chiu AY; Dal Canto MC; Polchow CY; Alexander DD; Caliendo J; Hentati A; Kwon YW; Deng HX
    Science; 1994 Jun; 264(5166):1772-5. PubMed ID: 8209258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Liu R; Althaus JS; Ellerbrock BR; Becker DA; Gurney ME
    Ann Neurol; 1998 Nov; 44(5):763-70. PubMed ID: 9818932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
    Morrison BM; Morrison JH; Gordon JW
    J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
    Turner BJ; Talbot K
    Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
    Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
    Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
    Dalle-Donne I
    Free Radic Biol Med; 2007 Jul; 43(2):157-9. PubMed ID: 17603924
    [No Abstract]   [Full Text] [Related]  

  • 14. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis.
    Dupuis L; Mbebi C; Gonzalez de Aguilar JL; Rene F; Muller A; de Tapia M; Loeffler JP
    Mol Cell Neurosci; 2002 Feb; 19(2):216-24. PubMed ID: 11860274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis.
    Parkhouse WS; Cunningham L; McFee I; Miller JM; Whitney D; Pelech SL; Krieger C
    Amyotroph Lateral Scler; 2008; 9(1):24-34. PubMed ID: 18273716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
    Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
    Calabrese V
    Free Radic Biol Med; 2007 Jul; 43(2):160-2. PubMed ID: 17603925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide-dependent peroxidase activity of H48Q: a superoxide dismutase variant associated with familial amyotrophic lateral sclerosis.
    Liochev SI; Chen LL; Hallewell RA; Fridovich I
    Arch Biochem Biophys; 1997 Oct; 346(2):263-8. PubMed ID: 9343373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper, zinc superoxide dismutase (SOD1) and its role in neuronal function and disease with particular relevance to motor neurone disease/amyotrophic lateral sclerosis.
    de Belleroche J; Orrell RW; Virgo L; Habgood J; Gardiner IM; Malaspina A; Kaushik N; Mitchell J; Greenwood J
    Biochem Soc Trans; 1998 Aug; 26(3):476-80. PubMed ID: 9765899
    [No Abstract]   [Full Text] [Related]  

  • 20. Superoxide dismutase activity in lymphoblastoid cells from motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) patients.
    Garofalo O; Figlewicz DA; Thomas SM; Butler R; Lebuis L; Rouleau G; Meininger V; Leigh PN
    J Neurol Sci; 1995 May; 129 Suppl():90-2. PubMed ID: 7595631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.